Today: 20 May 2026
Celsius (CELH) stock jumps after earnings; traders watch margins and distribution reset
26 February 2026
2 mins read

Celsius (CELH) stock jumps after earnings; traders watch margins and distribution reset

NEW YORK, Feb 26, 2026, 15:46 (EST) — Regular session

Celsius Holdings Inc (CELH) climbed 7.2% to $54.25 Thursday afternoon, boosted by its latest quarterly numbers. Earlier in the session, the energy drink stock spiked nearly 17%, before pulling back from those highs; it previously settled at $50.61.

The report arrives at a tricky point for the name. Investors are still picking apart genuine demand versus inventory simply circulating in the supply chain following a big change in distribution.

Margins are facing their own squeeze. Celsius says profitability should return to normal once integration efforts ease off and regular order flows resume, leaving behind the recent bursts.

Celsius posted a 117% surge in fourth-quarter revenue to $721.6 million, while non-GAAP adjusted diluted EPS climbed to $0.26 compared to $0.14 last year. Adjusted numbers exclude items Celsius considers outside its core operations. Gross margin narrowed to 47.4% from 50.2%, hit by integration costs, tariffs, and Rockstar Energy-related dilution. The company expects margins to recover to the low 50s once integrations wrap up in the first half of 2026. Celsius also paid back $197.8 million in debt and repurchased $39.8 million in stock during the quarter. CEO John Fieldly described 2025 as “a defining year.” Business Wire

The quarter underscored just how turbulent transitions can be. Celsius saw core CELSIUS brand revenue slide roughly 8% as shipments, distributor depletions—a stand-in for product flow into stores—and promotions all fell out of alignment. The company insisted this didn’t reflect actual retail demand, pointing to a 13% jump in U.S. tracked retail sales over the 13-week stretch ending Dec. 28. Celsius also booked a $327.5 million buyout obligation connected to distributor terminations. Distribution for Alani Nu in PepsiCo’s network hit 94.2% ACV in early February, its measure for shelf reach.

Celsius notched up gains Thursday, bucking the broader market’s slide as U.S. indexes dropped. Nvidia’s earnings pressured chip stocks, dragging the Nasdaq down.

Some investors have been too focused on short-term concerns, missing a larger trend in the energy drink space, UBS analyst Peter Grom told Barron’s. Grom, who rates the stock a buy with a $70 price target, said the portfolio continues to gain share.

Monster Beverage, a main competitor, will deliver its quarterly numbers after the bell. Analysts are zeroed in on pricing power and whether it’s enough to balance out a jump in aluminum expenses. RBC Capital is forecasting “a strong Jan sales number (16-19%)” for Monster—a gauge for the sector as Celsius and other brands keep the pressure on. Investing.com

The margin rebound at Celsius is the next test—does it come through fast after integration tasks are out of the way, or does a tough promo landscape drag things out? With shares slipping off their highs late in the session, investors are still watching execution more closely than the surface-level results.

Monster’s numbers drop after the bell, with traders eyeing the results for signals on energy-drink demand and pricing. As for Celsius, the buzz is quieter—focus now is on whether cleaner shipment trends and more stable margins can carry through the first half of 2026.

Stock Market Today

  • Sensex Falls 670 Points, Nifty Below 23,400 on Iran Tensions
    May 20, 2026, 1:50 AM EDT. The BSE Sensex tumbled 672 points, or 0.89%, to 74,529 amid heightened geopolitical risks following U.S. President Donald Trump's renewed threats against Iran. The NSE Nifty50 declined 220 points, or 0.94%, slipping below the key 23,400 level to close at 23,397. Defensive and steel stocks such as Bharat Electronics (BEL), Tata Steel, and Zomato faced sharp losses. The market reacted to escalating tensions in the Middle East, with investors retreating amid uncertainty. The fresh Iran threat weighed heavily on sentiment, disrupting a cautious recovery seen in recent sessions. Traders remain cautious of further volatility linked to geopolitical developments.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
Vertiv (VRT) stock price dips from record as AI valuation worries bite again
Previous Story

Vertiv (VRT) stock price dips from record as AI valuation worries bite again

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Next Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

Go toTop